Course Description

This 3.5-day program will cover guidelines, recommendations, and recent advances regarding therapeutic options for patients with solid tumors and hematologic disorders. At the end of the course, physicians will leave with a comprehensive syllabus, a self-assessment, and a deeper understanding of the pathogenesis, diagnostic evaluation, and therapeutic modalities available for a breadth of solid tumors as well as hematologic disorders.  There will be a case-based review session and discussions. The course will be designed to help prepare you for certifying and re-certifying exams as applicable.

Intended Audience

The target audience for this activity will be physicians and allied health professionals with a hematology/oncology focus who desire a review and update in current standards of care for patients. The course will be helpful to those preparing for certification or re-certification.


Main SCCA logo color - for website use - reduced w              UWLogo_Black